Elaine Heron

Elaine J.
Heron is currently Director at Visgenx, Inc. since 2019; Director at Watershed Medical Inc. since 2021; Director at Enumera Molecular, Inc.; Director at BlueWhale Bio, Inc. since 2023; Director at Zephyrus Biosciences, Inc.; Director at Vala Sciences, Inc.; Director at Palvella Therapeutics, Inc. since 2018 and Independent Director there since 2024; Director at Dropworks, Inc.; Director at Aro Biotherapeutics Co.; Independent Director at Vaxart, Inc. since 2022.
Former roles include Chairmen & Chief Executive Officer at Labcyte, Inc. from 2001 to 2008; Chairman & Chief Executive Officer at Amplyx Pharmaceuticals, Inc. from 2009 to 2015; Chairman-Life Science Screening at Kyto Technology & Life Science, Inc.; Director-Marketing at Molecular Dynamics, Inc.; Director at Insmed, Inc., Fluxion Biosciences, Inc., Bavarian Nordic A, Revolution Medicines, Inc., and Context Therapeutics LLC; Independent Non-Executive Director at BioMarin Pharmaceutical, Inc. from 2014 to 2025; Vice President at Applied Biosystems, Inc. from 2011 to 2013; Vice President-Marketing at Affymetrix, Inc. from 1995 to 1996; General Manager, Vice President-Sales & Marketing at Applera Corp.; General Manager at Applied Biosystems Group.
Education includes an MBA from Pepperdine University and undergraduate and doctorate degrees from Purdue University.